RESEARCH · RESEARCH · #888
Anthropic says Claude autonomously found a novel enzyme system in bacteriophages
Anthropic reports that nearly 950 Claude agents analyzed 210 million tokens over 21 hours and flagged an unusual repeating pattern that led to the identification and lab validation of a previously uncharacterized enzyme system in bacteriophages; the company compared the system to CRISPR but says its function and practical applications remain unclear. Anthropic says scientists limited their role to the initial prompt and follow-up lab work and published the early result to demonstrate Claude's capabilities.
KEY POINTS
- Anthropic reports that nearly 950 Claude agents analyzed 210 million tokens over 21 hours and flagged an unusual repeating pattern that led to the identification and lab validation of a previously uncharacterized enzyme system in bacteriophages; the company compared the system to CRISPR but says its function and practical applications remain unclear.
- Anthropic says scientists limited their role to the initial prompt and follow-up lab work and published the early result to demonstrate Claude's capabilities.
- If validated, an AI-aided discovery of a new enzyme system could accelerate AI-driven biological research, but the claim is preliminary and its practical significance is currently uncertain.
DECISION BRIEF
CONFIDENCE
WHAT CHANGED
Anthropic announced that its Claude agents autonomously identified a previously uncharacterized enzyme system associated with an array of DNA repeats in bacteriophages. The company says nearly 950 Claude agents processed ~210 million tokens over 21 hours before flagging the pattern; follow-up human-run lab experiments were used to validate the system. Anthropic compared the system to CRISPR-like machinery but says its function and practical applications remain unclear.
WHY NOW
This announcement is the first public result from Anthropic’s newly formed life‑sciences research group and Bay Area wet lab (formed in spring 2026) and is presented to demonstrate Claude’s capacity to search large genomic datasets and generate testable hypotheses. It arrives amid industry debate about deploying powerful AI systems into biological research and questions over AI’s autonomy in such work.
WHO IS AFFECTED
Directly affected actors: Anthropic and its life‑sciences team and lab; the Claude model/agent workflows used in the analysis; researchers working on genome mining, CRISPR and bacteriophage biology; and the broader scientific community that would need to validate and interpret the finding.
CONFIRMED
Explicit, source-backed facts: - Anthropic reports Claude autonomously discovered a novel enzyme system associated with DNA repeats and compared it to CRISPR-like machinery (1054, 1053). - Anthropic says nearly 950 Claude agents processed ~210 million tokens over a 21‑hour run before identifying the pattern (1053, 1075). - The system was found in bacteriophages and is linked to reverse transcriptases (RTs); one report says the system is dubbed “ART” and appears mostly in bacteriophages (1054, 1157). - Anthropic states scientists limited their role to the initial prompt and to running follow‑up lab experiments (1054, 1053, 1075). - Anthropic has published the early result to demonstrate Claude’s capabilities and to share what it is working on (1054, 1053). - Media reports note some CRISPR researchers characterized the announcement as routine genome mining and said similar systems have been known previously (1157). - TechCrunch reports Anthropic’s CEO acknowledged prior related work and said a Stanford team had previously discovered a system “in some ways similar” (1075).
UNCERTAIN
Key uncertainties and missing/conflicting evidence (explicitly labeled): - Function uncertain: Anthropic states the system’s function and practical applications are unknown (1054, 1053). Missing: no published functional demonstration showing the system performs cutting/copying/pasting operations in cells beyond initial lab checks (missing in provided excerpts). - Novelty uncertain/conflicting: Some CRISPR researchers call the finding routine genome mining and note similar systems have been reported before (1157). Missing/conflict: details comparing the new system’s sequence, structure, and activity to previously described systems are not provided in the excerpts. - Validation uncertain: there is no citation in the excerpts to a peer‑reviewed paper, public sequence dataset, or independent replication (missing). - Degree of autonomy uncertain: Anthropic claims most of the analysis was done by Claude but also notes humans performed experiments; exact breakdown of human vs agent steps and oversight is not detailed in the excerpts (missing). - Safety/dual‑use assessment: no evidence in the excerpts of external safety review, risk assessment, or release controls (missing). - Conflicting evidence: media reporting and expert comments dispute the significance and novelty of the announcement (1157).
WHAT TO WATCH
Concrete, observable signals to watch next: - Publication of a peer‑reviewed paper or preprint detailing the sequences, analysis methods, and experimental protocols (release of DOI/preprint server entry). - Public release of the nucleotide/amino‑acid sequences and computational code/agent workflows used to find the system (data repository links or GitHub). - Independent groups or established labs (including the Stanford team referenced) publishing analyses or experimental replications confirming or refuting enzymatic activity and mechanism. - Detailed lab results showing defined biochemical activity (e.g., assays demonstrating cutting, reverse transcription activity, or programmable targeting) and experimental conditions. - Additional statements or clarifications from Anthropic about the exact division of labor between Claude agents and human researchers, and any internal/external safety review. - Responses from the CRISPR/genome‑mining community documenting whether the system is novel compared to previously reported systems (e.g., citations to 2008 and subsequent work).
WHY IT MATTERS
If validated, an AI-aided discovery of a new enzyme system could accelerate AI-driven biological research, but the claim is preliminary and its practical significance is currently uncertain.
EVIDENCE MAP
4Editorial claims linked to specific sources, with support, contradiction and context shown separately.
Anthropic reports that Claude autonomously discovered a novel enzyme system associated with an array of DNA repeats, described as reminiscent of CRISPR.
SUPPORTEDChecked 2026-09-24 · 3 supporting
The Verge reports Anthropic's claim that Claude found a 'novel enzyme system' after scanning DNA sequences and notes the CRISPR comparison.
SUPPORTS AnthropicMEDIA · 2026-09-24Anthropic's post says Claude 'autonomously discovered a novel enzyme system' associated with DNA repeats and compares its properties to CRISPR-like systems.
SUPPORTS TechCrunch AIMEDIA · 2026-09-24TechCrunch summarizes Anthropic's announcement that the lab found a previously unknown enzyme system and mentions the CRISPR-like framing.
Anthropic says nearly 950 Claude agents processed about 210 million tokens over roughly 21 hours to detect the unusual repeating pattern that led to the finding.
SUPPORTEDChecked 2026-09-24 · 3 supporting
The Verge reports 'nearly 950 Claude agents', '21 hours' and '210 million tokens' as Anthropic's account of the search effort.
SUPPORTS TechCrunch AIMEDIA · 2026-09-24TechCrunch recounts Anthropic's claim that the work took 21 hours with about 950 agents and 210 million tokens.
SUPPORTS The DecoderMEDIA · 2026-09-24The Decoder also states 'about 950 AI agents' worked 21 hours and references the dataset scale in its report.
Anthropic and media reports say the system was identified in bacteriophages, but its function and practical applications remain unknown.
SUPPORTEDChecked 2026-09-24 · 3 supporting
The Verge states the enzyme system was found in bacteriophages and quotes Anthropic saying it is still working to understand what the system does.
SUPPORTS AnthropicMEDIA · 2026-09-24Anthropic's post says the system's function is not yet known and describes its characteristics; it does not claim demonstrated practical applications.
SUPPORTS TechCrunch AIMEDIA · 2026-09-24TechCrunch reports the finding 'in the DNA of bacteriophages' and notes Anthropic says the function remains unclear.
Anthropic says human scientists' involvement was limited to giving high-level direction (initial prompt) and performing follow-up lab experiments; the company presented the result publicly to demonstrate Claude's capabilities.
SUPPORTEDChecked 2026-09-24 · 3 supporting
The Verge reports Anthropic's claim that scientists' involvement was limited to the initial prompt and subsequent lab work and that the company shared findings to show Claude's capabilities.
SUPPORTS AnthropicMEDIA · 2026-09-24Anthropic states scientists provided only high-level direction and that agents collaborated with humans across the workflow; the post frames the publication as an early demonstration.
SUPPORTS TechCrunch AIMEDIA · 2026-09-24TechCrunch notes Anthropic emphasized the discovery was 'mostly, though not entirely, by Claude' and that humans ran the lab follow-up.
SOURCES & TIMELINE
4We’re introducing a new life sciences research group and laboratory at Anthropic. Our focus is on fundamental biology research using Claude: exploring datasets of DNA to identify uncharacterized protein families, generating hypotheses at scale, and testing them through experiments in the lab. This post introduces the team behind this work and shares early results in which Claude discovered a novel enzyme system with …
Last week, Anthropic confirmed that it was operating a wet biology lab in the Bay Area where it uses its AI models to run physical experiments. This week, the AI giant announced that this lab has already made what it believes is a big discovery: a new enzyme “system” that has certain “properties reminiscent of CRISPR,” as Anthropic describes it . CRISPR is a natural immune system used by bacteria to fight off viruse…
It took nearly 1,000 Claude agents 21 hours and 210 million tokens to uncover the ‘novel enzyme system.’ Anthropic says its AI Claude has “autonomously discovered” a new enzyme system similar to machinery behind the powerful gene-editing tool Crispr. It’s the first result from Anthropic’s newly-launched wet lab and an early test of Claude’s usefulness for science as the company prepares to go public. The company sa…
Anthropic's AI model Claude found a previously unknown enzyme system in DNA databases, doing most of the analysis on its own. Humans set the research question and ran the lab experiments. The system resembles the gene-editing tool CRISPR. Anthropic calls it one of the first discoveries from its Bay Area biology lab, which opened in spring 2026 . About 950 AI agents spent 21 hours combing through more than 200,000 re…